Cutaneous T Cell Lymphoma News and Research

RSS
Deadly subtype of T-cell lymphoma harbors unique mutations

Deadly subtype of T-cell lymphoma harbors unique mutations

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

Cancer risk in psoriatic patients

Cancer risk in psoriatic patients

Pre-existing anticancer drug could help treat common form of heart failure

Pre-existing anticancer drug could help treat common form of heart failure

Discovery could unlock new ways to treat a rare blood disease

Discovery could unlock new ways to treat a rare blood disease

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Researchers analyze precise mechanism of binding reaction in PUVA therapy

Researchers analyze precise mechanism of binding reaction in PUVA therapy

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Penn study forms basis for new treatment approaches for Sezary syndrome

Penn study forms basis for new treatment approaches for Sezary syndrome

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Mylan announces launch of Bexarotene 75mg Capsules in U.S.

Mylan announces launch of Bexarotene 75mg Capsules in U.S.

May issue of Red Journal focuses on role of radiation therapy in current lymphoma treatment

May issue of Red Journal focuses on role of radiation therapy in current lymphoma treatment

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

Soligenix's SGX301 receives FDA 'Fast Track' designation for CTCL treatment

Soligenix closes previously announced registered public offering

Soligenix closes previously announced registered public offering